Effector function of diabetogenic CD4 Th1 T cell clones:: A central role for TNF-α

被引:40
作者
Cantor, J
Haskins, K
机构
[1] Univ Colorado, Dept Immunol, Natl Jewish Med & Res Ctr, Hlth Sci Ctr, Denver, CO 80206 USA
[2] Univ Colorado, Hlth Sci Ctr, Dept Immunol, Denver, CO 80206 USA
[3] Univ Colorado, Hlth Sci Ctr, Barbara Davis Ctr Childhood Diabet, Denver, CO 80206 USA
关键词
D O I
10.4049/jimmunol.175.11.7738
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Effector function of T cells in autoimmune diabetes has been widely studied with mixed populations of lymphoid T cells stimulated ex vivo, but this approach does not permit evaluation of the contribution by a single T cell clone in the inflammatory site during pathogenesis. We have investigated cytokine production both in vitro and in vivo in a panel of diabetogenic CD4 Th1 T cell clones derived from the NOD mouse. SuperArray analysis showed a common pattern of mRNA expression for inflammatory cytokines and receptors in vitro after TCR stimulation. Ex vivo intracellular cytokine staining demonstrated that two important inflammatory cytokines, IFN-gamma and TNF-alpha, were being made by these T cells recovered from the pancreas 6 days following adoptive transfer. TNF-a produced in the pancreas by pathogenic T cell clones and recruited macrophages was not the membrane-bound form. Secreted TNF-a can lead to production of multiple inflammatory chemokines, as were observed in the pathogenic clones by intracellular cytokine staining. Our results not only define the nature of an inflammatory cytokine response critical to development of diabetes, but also suggest its role in the regulation of other events during pathogenesis induced by CD4 T cells. Similar analyses in other models demonstrated that disease induced by CD4 T cell clones closely resembles spontaneous autoimmune diabetes in which both CD4 and CD8 T cells are required. Thus, cloned T cells in effect amplify effector function of T cells which otherwise may be difficult to detect without ex vivo stimulation.
引用
收藏
页码:7738 / 7745
页数:8
相关论文
共 23 条
[1]   A mechanism for IL-10-mediated diabetes in the nonobese diabetic (NOD) mouse: ICAM-1 deficiency blocks accelerated diabetes [J].
Balasa, B ;
La Cava, A ;
Van Gunst, K ;
Mocnik, L ;
Balakrishna, D ;
Nguyen, N ;
Tucker, L ;
Sarvetnick, N .
JOURNAL OF IMMUNOLOGY, 2000, 165 (12) :7330-7337
[2]   ISLET-SPECIFIC T-CELL CLONES FROM THE NOD MOUSE RESPOND TO BETA-GRANULE ANTIGEN [J].
BERGMAN, B ;
HASKINS, K .
DIABETES, 1994, 43 (02) :197-203
[3]   The effect of simultaneous CD154 and LFA-1 blockade on the survival of allogeneic islet grafts in nonobese diabetic mice [J].
Berney, T ;
Pileggi, A ;
Molano, RD ;
Poggioli, R ;
Zahr, E ;
Ricordi, C ;
Inverardi, L .
TRANSPLANTATION, 2003, 76 (12) :1669-1674
[4]   Tumor necrosis factor-α converting enzyme [J].
Black, RA .
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2002, 34 (01) :1-5
[5]  
Bradley LM, 1999, J IMMUNOL, V162, P2511
[6]   Differential expression of CC chemokines and the CCR5 receptor in the pancreas is associated with progression to type I diabetes [J].
Cameron, MJ ;
Arreaza, GA ;
Grattan, M ;
Meagher, C ;
Sharif, S ;
Burdick, MD ;
Strieter, RM ;
Cook, DN ;
Delovitch, TL .
JOURNAL OF IMMUNOLOGY, 2000, 165 (02) :1102-1110
[7]   Single-cell analysis of the murine chemokines MIP-1α, MIP-1β, RANTES and ATAC/lymphotactin by flow cytometry [J].
Dorner, BG ;
Steinbach, S ;
Hüser, MB ;
Kroczek, RA ;
Scheffold, A .
JOURNAL OF IMMUNOLOGICAL METHODS, 2003, 274 (1-2) :83-91
[8]   THE TRANSMEMBRANE FORM OF TUMOR-NECROSIS-FACTOR IS THE PRIME ACTIVATING LIGAND OF THE 80 KDA TUMOR-NECROSIS-FACTOR RECEPTOR [J].
GRELL, M ;
DOUNI, E ;
WAJANT, H ;
LOHDEN, M ;
CLAUSS, M ;
MAXEINER, B ;
GEORGOPOULOS, S ;
LESSLAUER, W ;
KOLLIAS, G ;
PFIZENMAIER, K ;
SCHEURICH, P .
CELL, 1995, 83 (05) :793-802
[9]  
Hänninen A, 1998, J IMMUNOL, V160, P6018
[10]   PREVENTION OF AUTOIMMUNE INSULIN-DEPENDENT DIABETES IN NONOBESE DIABETIC MICE BY ANTI-LFA-1 AND ANTI-ICAM-1 MAB [J].
HASEGAWA, Y ;
YOKONO, K ;
TAKI, T ;
AMANO, K ;
TOMINAGA, Y ;
YONEDA, R ;
YAGI, N ;
MAEDA, S ;
YAGITA, H ;
OKUMURA, K ;
KASUGA, M .
INTERNATIONAL IMMUNOLOGY, 1994, 6 (06) :831-838